Caffeine in Food and Dietary Supplements Examining Safety: Workshop Summary (2014) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 167-174
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 167... ...
A Workshop Agenda Caffeine in Food and Dietary Supplements: Examining Safety Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements The National Academies Lecture Room 2101 Constitution Avenue NW Washington, DC 20418 August 5–6, 2013 WORKSHOP OBJECTIVES Evaluate the epidemiological, toxicological, clinical, and other relevant literature to describe important health hazards associated with caffeine consumption Delineate vulnerable populations who may be at risk from caf feine exposure Describe caffeine exposure and risk of cardiovascular and other health effects on vulnerable populations, including additive effects with other ingredients and effects related to preexisting conditions Explore safe caffeine exposure levels for general and vulnerable populations Identify data gaps on caffeine stimulant effects including but not limited to cardiovascular, central nervous system, or other health outcomes 167
|
From page 168... ...
Welcome Lynn Goldman, George Washington University, Chair, Planning Committee on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements 9:00 a.m. Opening Remarks Margaret Hamburg, Commissioner of Food and Drugs, Food and Drug Administration SESSION 1: INTAKE AND EXPOSURE TO CAFFEINE Moderated by Barbara Petersen, Exponent 9:15 a.m.
|
From page 169... ...
and International Surveillance Alvin Bronstein, Rocky Mountain Poison Center 11:10 a.m. Safety Assessment of Caffeine in Foods and Beverages Ashley Roberts, Intertek Cantox Consulting (by WebEx)
|
From page 170... ...
Break SESSION 5: PANEL DISCUSSION: BEHAVIORAL EFFECTS ASSOCIATED WITH CAFFEINE CONSUMPTION Moderated by Richard Adamson, TPN Associates 3:30 p.m. Dependence/Tolerance Roland Griffiths, Johns Hopkins University Addiction Charles O'Brien, University of Pennsylvania Risk Taking Amelia Arria, University of Maryland, College Park 4:30 p.m.
|
From page 171... ...
Opening Remarks Michael Taylor, Deputy Commissioner for Foods and Veterinary Medicine, Food and Drug Administration SESSION 1: OTHER COMPOUNDS IMPACTING CAFFEINE EFFECTS Moderated by James Coughlin, Coughlin & Associates 9:15 a.m. Facilitated Discussion: Other Components Im pacting Caffeine Effects Led by Stephen Schaffer, University of South Alabama Summary of the Issues Stephen Schaffer Panel Discussion Speakers from Day 1
|
From page 172... ...
Q&A SESSION 3: EXPLORING SAFE CAFFEINE EXPOSURE LEVELS 10:45 a.m. Panel Discussion: Exploring Safe Caffeine Exposure Levels for Vulnerable Populations Panel Moderator Mark Feeley, Health Canada Pregnancy/Infants Christina Chambers, University of California, San Diego Children/ Young Adults Steve Lipshultz, University of Miami 11:30 a.m.
|
From page 173... ...
Adjourn Meeting
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.